ATRC Logo

AtriCure, Inc. (ATRC) 

NASDAQ
Market Cap
$1.49B
Sector
Healthcare
Industry
Medical—Instruments & Supplies
Rank in Sector
288 of 958
Rank in Industry
17 of 49

Largest Insider Buys in Sector

ATRC Stock Price History Chart

ATRC Stock Performance

About AtriCure, Inc.

AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and …

Insider Activity of AtriCure, Inc.

Over the last 12 months, insiders at AtriCure, Inc. have bought $111,250 and sold $589,177 worth of AtriCure, Inc. stock.

On average, over the past 5 years, insiders at AtriCure, Inc. have bought $204,842 and sold $12.51M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Privitera Salvatore (Chief Technical Officer) — $111,250.

The last purchase of 5,000 shares for transaction amount of $111,250 was made by Privitera Salvatore (Chief Technical Officer) on 2024‑05‑30.

List of Insider Buy and Sell Transactions, AtriCure, Inc.

2024-08-15Saledirector
3,500
0.0082%
$24.07$84,2450.00%
2024-05-30PurchaseChief Technical Officer
5,000
0.0103%
$22.25$111,250+22.47%
2024-05-01SaleChief Mktg & Strategy Officer
1,500
0.003%
$24.09$36,135+5.42%
2024-04-01SaleChief Mktg & Strategy Officer
1,500
0.0033%
$30.39$45,585-12.00%
2024-03-18SaleChief Legal Officer
1,885
0.004%
$32.16$60,622-18.13%
2024-03-12SaleChief Mktg & Strategy Officer
1,500
0.0033%
$36.72$55,080-25.18%
2024-03-05SaleChief Legal Officer
8,231
0.0172%
$37.36$307,510-30.59%
2023-11-01SaleChief Legal Officer
1,248
0.0026%
$34.43$42,969-18.48%
2023-07-26SaleChief Legal Officer
3,417
0.008%
$57.09$195,077-40.50%
2023-06-08Saledirector
713
0.0015%
$47.89$34,146-25.66%
2023-06-06SaleChief Legal Officer
1,422
0.003%
$47.03$66,877-26.36%
2023-05-26Saledirector
4,313
0.0094%
$47.04$202,884-22.60%
2023-05-01SaleChief Legal Officer
4,417
0.0095%
$44.83$198,014-16.80%
2022-05-13SaleChief Human Resources Officer
3,203
0.007%
$42.69$136,736-0.84%
2022-04-08SaleChief Human Resources Officer
282
0.0006%
$61.59$17,368-30.04%
2022-03-04SaleChief Human Resources Officer
1,409
0.0031%
$67.66$95,333-35.60%
2022-03-02SaleChief Human Resources Officer
3,259
0.0071%
$70.40$229,434-38.89%
2022-02-11SaleChief Human Resources Officer
2,490
0.0057%
$67.97$169,245-32.51%
2022-01-14SaleChief Human Resources Officer
2,719
0.006%
$66.11$179,753-30.89%
2021-12-10SaleChief Human Resources Officer
1,528
0.0035%
$70.88$108,305-31.51%

Insider Historical Profitability

24.75%
Privitera SalvatoreChief Technical Officer
103290
0.2119%
$30.50111
Discovery Group I, LLC10 percent owner
1621334
3.3256%
$30.504725+15.37%
ROBARDS KAREN Pdirector
288328
0.5914%
$30.50233+76.77%
Drachman David JPresident and CEO
146000
0.2995%
$30.50415<0.0001%
Piton Julie AVP Fin & Admin & CFO
85922
0.1762%
$30.5012<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
The Vanguard Group$144.59M9.824.75M-0.27%-$396,798.48<0.01
BlackRock$128.71M8.744.23M+0.89%+$1.13M<0.01
AllianceBernstein$111.12M7.553.65M+7.62%+$7.87M0.04
Champlain Investment Partners, LLC$81.56M5.542.68M+27.34%+$17.51M0.47
Fidelity Investments$75.36M5.122.48M+3,164.47%+$73.05M0.01
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.